Athanasios D Anastasilakis Selected Research

Athanasios D Anastasilakis Research Topics

Disease

26	Osteoporosis 01/2022 - 03/2008
11	Postmenopausal Osteoporosis 01/2021 - 03/2008
8	Non-alcoholic Fatty Liver Disease 01/2022 - 06/2015
6	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2019 - 01/2012
5	Metabolic Bone Diseases (Osteopenia) 12/2021 - 07/2007
4	Hyperostosis corticalis deformans juvenilis 12/2019 - 11/2010
4	Bone Resorption 02/2015 - 05/2010
4	Osteitis Deformans (Paget's Disease of Bone) 01/2012 - 09/2009
3	Bone Diseases (Bone Disease) 01/2022 - 03/2014
3	Neoplasms (Cancer) 01/2022 - 08/2009
3	Necrosis 01/2017 - 12/2012
3	Insulin Resistance 02/2014 - 09/2011
3	Acute-Phase Reaction 12/2012 - 05/2011
2	Pain (Aches) 02/2022 - 01/2017
2	Osteonecrosis (Kienbock's Disease) 01/2022 - 01/2022
2	Primary Hyperparathyroidism 02/2021 - 04/2020
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 02/2021 - 04/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 12/2019
2	Endocrine System Diseases (Endocrine Diseases) 03/2019 - 07/2018
2	Myocardial Infarction 02/2019 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2019 - 01/2017
2	Pathologic Constriction (Stenosis) 02/2019 - 01/2017
2	Amenorrhea 01/2018 - 11/2014
2	Rare Diseases (Rare Disease) 02/2015 - 04/2012
2	Hypocalcemia 03/2014 - 11/2010
1	Endometriosis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Carcinogenesis 02/2021
1	Dermatomyositis (Dermatopolymyositis) 06/2020
1	Aneurysmal Bone Cysts 12/2019
1	Hajdu-Cheney Syndrome (Multicentric Osteolysis) 12/2019
1	Osteogenesis Imperfecta (Lobstein Disease) 12/2019

Drug/Important Bio-Agent (IBA)

17	Denosumab FDA Link 01/2022 - 07/2011
15	Zoledronic Acid (Zometa)FDA Link 12/2021 - 09/2009
9	Diphosphonates (Bisphosphonates)IBA 02/2022 - 07/2007
8	Teriparatide (Parathar)FDA Link 11/2021 - 03/2008
5	OsteoprotegerinIBA 12/2019 - 03/2008
5	PeriostinIBA 05/2017 - 05/2015
4	Bone Density Conservation AgentsIBA 01/2022 - 07/2007
4	MicroRNAs (MicroRNA)IBA 02/2021 - 02/2017
4	FollistatinIBA 01/2020 - 10/2016
4	Parathyroid Hormone (Parathormone)IBA 03/2019 - 01/2010
4	LeptinIBA 01/2018 - 12/2012
4	CytokinesIBA 02/2015 - 06/2011
3	Monoclonal AntibodiesIBA 12/2019 - 07/2011
3	AdipokinesIBA 01/2013 - 09/2011
2	Vitamin E FDA LinkGeneric 01/2022 - 12/2018
2	Pharmaceutical PreparationsIBA 03/2021 - 07/2016
2	Risedronic Acid (Actonel)FDA LinkGeneric 01/2021 - 03/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2011
2	Activins (Activin)IBA 01/2020 - 01/2018
2	LipidsIBA 12/2019 - 07/2019
2	CalciumIBA 03/2019 - 04/2009
2	Carrier Proteins (Binding Protein)IBA 02/2019 - 10/2016
2	Insulin (Novolin)FDA Link 02/2019 - 01/2013
2	Anabolic AgentsIBA 10/2017 - 07/2011
2	Biomarkers (Surrogate Marker)IBA 02/2017 - 01/2012
2	activin AIBA 01/2017 - 10/2016
2	C-Reactive ProteinIBA 12/2015 - 12/2012
2	HomocysteineIBA 06/2015 - 05/2010
2	AdiponectinIBA 02/2014 - 09/2011
2	Methotrexate (Mexate)FDA LinkGeneric 11/2013 - 01/2013
2	Antirheumatic Agents (DMARD)IBA 11/2013 - 01/2013
1	Goserelin (Zoladex)FDA Link 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	CanagliflozinIBA 01/2022
1	obeticholic acidIBA 01/2022
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2022
1	semaglutideIBA 01/2022
1	Calcium-Sensing ReceptorsIBA 02/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2021
1	Cyclin D1IBA 02/2021
1	CateninsIBA 02/2021
1	Prednisolone (Predate)FDA LinkGeneric 06/2020
1	Methylprednisolone FDA LinkGeneric 06/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2020
1	GlicentinIBA 01/2020
1	Proglucagon (Glucagon Precursors)IBA 01/2020
1	OxyntomodulinIBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	Glucagon (Glukagon)FDA Link 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2020
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2020
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2020
1	activin BIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 12/2019
1	GlucocorticoidsIBA 12/2019
1	RANK LigandIBA 12/2019
1	Polysaccharides (Glycans)IBA 12/2019

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2008
2	Percutaneous Coronary Intervention 02/2019 - 01/2017
2	Aftercare (After-Treatment) 01/2012 - 04/2010
2	Injections 06/2010 - 03/2008
1	Conservative Treatment 01/2021
1	Contraindications 12/2019
1	Off-Label Use 12/2019